Stainless steel tank construction specialist Gpi Group has set up a new business unit under the name Gpi Pharma. This business unit encompasses all of Gpi’s experts in the design and production of pharmaceutical tanks, enabling the company to provide customers with faster, better service. The unit was set up in response to growing demand from the pharmaceutical industry, prompted in part by the Covid-19 pandemic. The Gpi Group has 25 years’ experience in pharma and is au fait with all design and production requirements. Whether it involves process tanks, mobile reactors or WFI tanks, Gpi engineers are fully familiar with the rules and regulations, such as ASME BPE and the EU’s Pressure Equipment Directive (PED). Through Gpi Pharma, the Group will seek to home in on the unique needs and requirements of pharma companies in a swifter, more targeted way. Gpi Pharma is founded on a combination of knowledge, expertise and experience. This combination will serve as the basis for the new business unit to provide its customers with optimum service and products of the highest quality. Fred Boere, CEO of the Gpi Group: ‘In part due to the Covid situation, we are seeing growing demand for high-quality pharmaceutical tanks and are expecting this trend to persist. Gpi Pharma is geared towards homing in on this demand by pooling our seasoned specialists in this area of expertise and providing customers with better service with a select team who know the pharma industry inside out’. Customers and prospects can find out more about the options on the website. Sales Manager Joost Nieuwlaat is responsible for sales. ‘I joined Gpi in January 2020 and have always been impressed by my colleagues’ expertise and dedication. Covid-19 is forcing us to act and supply swiftly. Our many years of experience, our considerable production capacity and our international network of suppliers mean that we will always be in a position to fulfil the shortest delivery times currently being requested. Without any detrimental effect on the requisite quality.’ The pharmaceutical industry has been increasingly popular with investors over the past few years and substantial investments are being made everywhere. The coronavirus pandemic has accelerated this development, particularly when it comes to vaccine production. Unsurprisingly, then, Gpi Pharma sees considerable potential for growth and intends to invest further in the business unit over the next few years. In the last 25 years, Gpi has built up a solid reputation as a successful international tank manufacturer. The company singles itself out by its constant innovations in the field of technology, processes and cooperation. The Gpi Group consists of four companies specialising in the construction of tanks and pressure vessels: Gpi Tanks, Gpi Tanks GmbH, Gpi Tanks Poland and Gpi Tanks XL. In addition, Gpi De Gouwe, specialist in processing equipment, and BMN (Beitserij Midden Nederland), expert in pickling, grinding and polishing, are also part of the group. Globally, the Gpi Group serves customers in the food-processing, chemical, pharmaceutical and cosmetics industries. Gpi Group has a total workforce of around 200 employees.

TanksPharmaceutical